From the Department of Plastic Surgery, M. D. Anderson Cancer Center.
Received for publication December 12, 2018; accepted December 18, 2018.
Disclosure:The author was a clinical investigator for the Athena trial (Mentor Corporation) and Motiva U.S. Safety Trial (Establishment Labs). He was a former Allergan consultant (2012 to 2015) and was provided travel expenses at an educational meeting.
Mark W. Clemens, M.D., Department of Plastic Surgery, M. D. Anderson Cancer Center, 1400 Pressler Street, Unit 1488, Houston, Texas 77030, email@example.com, Twitter: @clemensmd